Journal Mobile Options
Table of Contents
Vol. 86, No. 2, 2004
Issue release date: August 2004

Transferrin Microheterogeneity in Fetal Blood

Wu Y. · Sakamoto H. · Kanenishi K. · Tanaka S. · Ueno M. · Hata T.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Objectives: To investigate the distribution of microheterogeneous subfractions of transferrin in fetal blood and the influence of highly sialylated transferrins on fetal growth. Study Method: Serum transferrin concentrations were determined by a standard turbidimetric assay. Microheterogeneous transferrin subfractions were assessed by crossed immunoisoelectric focusing. Results: In normal term infants, total serum transferrin concentrations and percent distribution of highly sialylated transferrins (≧5-sialo-transferrins) were markedly lower; the percent distributions of hyposialylated transferrins (0- and 1-sialo-transferrins) were apparently higher than those in non-pregnant and pregnant women. There was no significant positive correlation between the serum concentrations of total transferrin or highly sialylated transferrins in infants’ blood and birth weights (r = 0.187, p = 0.582; r = 0.374, p = 0.257, respectively). Conclusion: The transferrin microheterogeneity pattern shifted towards reduced glycosylation and sialylation in addition to a decrease in total transferrin concentration in fetal blood compared to that of non-pregnant and pregnant women. The concentrations of serum total transferrin and the highly sialylated transferrins in fetal blood, if higher than a certain level, did not seem to have any influence on normal fetal growth.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Contractor SF, Eaton BM: Role of transferrin in iron transport between maternal and fetal circulations of a perfused lobule of human placenta. Cell Biochem Funct 1986;4:69–74.
  2. Harris ED: New insights into placental iron transport. Nutr Rev 1992;50:329–331.
  3. McFarlane H, Ogbeige MI, Reddy S, Adcock KJ, Adeshina H, Gurney JM, Cooke A, Taylor GO, Mordie JA: Biochemical assessment of protein calorie malnutrition. Lancet 1969;i:392–394.
  4. Olusi SO, Ademowore AS, Bola Ajani G: Biochemical assessment of the nutritional state of gravida of different socio-economic classes at the Wesley Guild Hospital, Ilesha, Nigeria. J Trop Med Hyg 1979;82:8–13.
  5. De Jong G, van Eijk HG: Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilized pH gradients. Electrophoresis 1988;9:589–598.
  6. De Jong G, van Dijk JP, van Eijk HG: The biology of transferrin. Clin Chim Acta 1990;190:1–46.
  7. Van Eijk HG, de Jong G: The physiology of iron, transferrin, and ferritin. Biol Trace Elem Res 1992;35:13–24.
  8. De Jong G, van Noort WL, Feelders RA, de Jeu-Jaspars CM, van Eijk HG: Adaptation of transferrin protein and glycan synthesis. Clin Chim Acta 1992;212:27–45.
  9. Wu YH, Sakamoto H, Kanenishi K, Li J, Khatun R, Hata T: Transferrin microheterogeneity in pregnancies with preeclampsia. Clin Chim Acta 2003;332:103–110.
  10. Parker WC, Bearn AG: Studies on the transferrins of adult serum, cord serum, and cerebrospinal fluid. The effect of neuraminidase. J Exp Med 1962;115:83–105.
  11. Parker WC, Hagstrom JWC, Bearn AG: Additional studies on the transferrins of cord serum and cerebrospinal fluid. J Exp Med 1963;118:975–989.
  12. Verrijt CE, Kroos MJ, Verhoeven AJ, van Eijk HG, van Dijk JP: Transferrin in cultured human term cytotrophoblast cells: Synthesis and heterogeneity. Mol Cell Biochem 1997;173:177–181.
  13. Rudolph JR, Regoeczi E, Chindemi PA, Southward S: The consequences of rat transferrin in microheterogeneity with particular reference to iron delivery to hepatocytes and liver. Proc 8th Int Conf on Proteins of Iron Transport and Storage. Montebello, Quebec 1987, p 97.
  14. Hu WL, Chindemi PA, Regoeczi E: Reduced hepatic iron uptake from rat aglycotransferrin. Biol Metals 1991;4:90–94.
  15. Hoefkens P, Huijskes-Heins MI, de Jeu-Jaspars CM, van Noort WL, van Eijk HG: Influence of transferrin glycans on receptor binding and iron-donation. Glycoconj J 1997;14:289–295.
  16. Chang LL, Sivasamboo R: Serum transferrin in cord blood and maternal blood. J Obstet Gynaecol Br Commonw 1973;80:1013–1016.
  17. Misaki M, Kumazawa M, Sugita M, Shima T, Okazaki T: A possible relationship between cord blood transferrin and birth length in infants. Horm Res 1987;25:228–231.
  18. Florence K, Vassiliki D, Vassiliki T, et al: Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 1995;41:605–608.
  19. Van Pelt J, Bakker JA, Velmans MH, Spaapen LJM: Carbohydrate-deficient transferrin values in neonatal and umbilical cord blood. J Inher Metab Dis 1996;19:253–256.
  20. Wong CT, Saha N: Lack of influence of maternal and fetal transferrin phenotypes and concentrations on normal fetal growth. Biol Neonate 1991;59:156–160.
  21. Dissanayake S, de Silva LVK: Transferrin in maternal and cord blood: The relationship with birth weight. J Trop Med Hyg 1984;87:167–171.
  22. Agarwal RK, Verma IC, Ghai OP: Cord and maternal serum transferrin as indicators of foetal malnutrition. Indian J Med Res 1985;82:434–438.
  23. Feelders RA, Vreugdenhil G, de Jong G, Swaak AJG, van Eijk HG: Transferrin microheterogeneity in rheumatoid arthritis. Rheumatol Int 1992;12:195–199.
  24. Klaassen CH, Fransen JA, Swarts HG, De Pont JJ: Glycosylation is essential for biosynthesis of functional gastric H+, K+-ATPase in insect cells. Biochem J 1997;321:419–424.
  25. Lis H, Sharon N: Protein glycosylation. Structural and functional aspects. Eur J Biochem 1993;218:1–27.
  26. Charbonneau J, Stanners CP: Role of carbohydrate structures in CEA-mediated intercellular adhesion. Cell Adhes Commun 1999;7:233–244.
  27. Gorman WL, Pridgen C, Portner A: Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties. Virology 1991;183:83–90.
  28. Davidge ST, Hubel CA, Brayden RD, Capeless EC, McLaughlin MK: Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 1992;79:897–901.
  29. Lindeman JH, Houdkamp E, Lentjes EG, Poorthuis BJ, Berger HM: Limited protection against iron-induced lipid peroxidation by cord blood plasma. Free Radic Res Commun 1992;16:285–294.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50